Search research articles
Contact Us
Filters
Showing results (481-490 of 486) with videos related to
Page
of 49
Sort By:
You have reached the last page of results.
This site can display upto 486 results.
Astrobiology
|
August 12, 2021
Habitability Models for Astrobiology
Abel Méndez, Edgard G Rivera-Valentín, Dirk Schulze-Makuch, et al.
ACS Chemical Biology
|
July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
Yury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
Med (New York, N.Y.)
|
August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
María Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.
RSC Chemical Biology
|
April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesicles
Darielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Vaccine
|
June 12, 2022
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
María Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, Meiby Rodríguez-González, et al.
Journal of Vascular Surgery
|
July 19, 2020
Managing central venous access during a health care crisis
Tristen T Chun, Dejah R Judelson, David Rigberg, et al.
Page
of 49
Search research articles
Search
Showing results (481-490 of 486) with videos related to
Sort By:
Page
of 49
You have reached the last page of results.
This site can display upto 486 results.
Astrobiology
|
August 12, 2021
Habitability Models for Astrobiology
Abel Méndez, Edgard G Rivera-Valentín, Dirk Schulze-Makuch, et al.
ACS Chemical Biology
|
July 5, 2021
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
Yury Valdes-Balbin, Darielys Santana-Mederos, Lauren Quintero, et al.
Med (New York, N.Y.)
|
August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
María Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.
RSC Chemical Biology
|
April 1, 2022
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and <i>Neisseria meningitidis</i> outer membrane vesicles
Darielys Santana-Mederos, Rocmira Perez-Nicado, Yanet Climent, et al.
Vaccine
|
June 12, 2022
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
María Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, Meiby Rodríguez-González, et al.
Journal of Vascular Surgery
|
July 19, 2020
Managing central venous access during a health care crisis
Tristen T Chun, Dejah R Judelson, David Rigberg, et al.
Page
of 49